MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fimmu.2024.1337557

Медицинская библиотека · Frontiers in immunology · 2024

Efficacy of MUC1-targeted CAR-NK cells against human tongue squamous cell carcinoma.

Lin Xiaolan, Guan Tian, Li Yun, Lin Yanchun, Huang Guowei, Lin Yan, Sun Pingnan, Li Congzhu, Gu Jiang, Zeng Haoyu, Ma Changchun

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

INTRODUCTION

The clinical efficacy of CAR-NK cells against CD19-expressing blood cancers has been demonstrated, and they have shown potential for treating solid tumors as well. However, the efficacy of CAR-NK cells for treating human oral tongue squamous cell carcinoma (OTSCC) has not been examined.

METHODS

We assessed MUC1 expression in human OTSCC tissue and a cell line using immunohistochemistry and immunofluorescence. We constructed NK cells that express CAR targeted to MUC1 from pluripotent stem cells (iPSC-derived MUC1-targeted CAR-NK cells) and evaluated their effectiveness against OTSCC in vitro using the xCELLigence Real-Time Cell Analysis system and CCK8 assay, and in vivo by measuring xenograft growth daily in BNDG mice treated with MUC1-targeted CAR-NK cells. As controls, we used iPSC-derived NK cells and NK-free media, which were CAR-free and blank, respectively.

RESULTS

MUC1 expression was detected in 79.5% (66/83) of all OTSCC patients and 72.7% (24/33) of stage III and IV. In stage III and IV MUC1 positive OTSCC, 63.6% (21/33) and 48.5% (16/33) patients had a MUC1-positive cancer cell rate of more than 50% and 80%, respectively. The iPSC-derived MUC1-targeted CAR-NK cells exhibited significant cytotoxicity against MUC1-expressing OTSCC cells in vitro, in a time- and dose-dependent manner, and showed a significant inhibitory effect on xenograft growth compared to both the iPSC-derived NK cells and the blank controls. We observed no weight loss, severe hematological toxicity or NK cell-mediated death in the BNDG mice.

CONCLUSION

The MUC1-targeted CAR-NK cells had significant efficacy against human OTSCC, and their promising therapeutic response warrants further clinical trials.

Для цитирования: Lin Xiaolan, Guan Tian, Li Yun, Lin Yanchun, Huang Guowei, Lin Yan, Sun Pingnan, Li Congzhu, Gu Jiang, Zeng Haoyu, Ma Changchun. Efficacy of MUC1-targeted CAR-NK cells against human tongue squamous cell carcinoma.. Frontiers in immunology. 2024. DOI: 10.3389/fimmu.2024.1337557.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.